OFEV vs TASIGNA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 18, 2026·How we rate

Possible drug interaction. OFEV and TASIGNA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	OFEV	TASIGNA
Rating	72/100	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	NINTEDANIB ESYLATE	NILOTINIB HYDROCHLORIDE
Manufacturer	Boehringer Ingelheim	Novartis
Dosage forms	Capsule	Capsule
Drug class	Kinase Inhibitor	Kinase Inhibitor
Boxed warning	None	Boxed warning
Treats	Idiopathic Pulmonary Fibrosis	Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia

ofev tasigna

Rating

72/100

70/100

Pharmacy pays

—

Type

Active ingredient

NINTEDANIB ESYLATE

NILOTINIB HYDROCHLORIDE

Manufacturer

Boehringer Ingelheim

Novartis

Dosage forms

Capsule

Drug class

Kinase Inhibitor

Boxed warning

None

Boxed warning

Treats

Idiopathic Pulmonary Fibrosis

Accelerated Phase Myeloid Leukemia, Chronic-Phase Myeloid Leukemia

Frequently asked questions

Which is better-rated, Ofev or Tasigna?

By our independent rating, Ofev scores higher — 3.6 vs 3.5 out of 5 for Tasigna. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Ofev and Tasigna?

Ofev contains Nintedanib Esylate, while Tasigna contains Nilotinib Hydrochloride — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.